So long as the federal government grossly overpays pharmaceutical companies for drugs, what is the justification for balancing the deficit on the backs of people with Medicare?
Read Whole Story
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.